AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KJUN 102 min read$UPB

Upstream Bio, Inc. (UPB): Submission of Matters to a Vote of Security Holders

Upstream Bio, Inc. (UPB) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K 0002022626 false 0002022626 2026-06-09 2026-06-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): June 09,

Original reporting
SEC EDGAR 8-K
Published Jun 10, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 10, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefCorporate actions
Primary signal
$UPB
Neutral
high confidence
Mentioned
$UPB
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$UPBNeutralLow
01

Why it matters

Confirms election of two Class II directors and ratification of PwC as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.

02

Market read

This is a procedural disclosure of annual meeting outcomes; it does not introduce new financial or regulatory catalysts.

03

What to watch

Check the referenced April 16, 2026 definitive proxy for any contested items or governance changes; this 8-K itself does not add those details.

Relevance 6/10Novelty 2/10Timing: after-hours / filing date (June 10, 2026)

Background

The company held its 2026 annual meeting of stockholders on June 9, 2026 and filed final voting results on Form 8-K.

Company-level read

Ticker impact

$UPBNeutralHigh confidence
Context

Upstream Bio filed an 8-K reporting final shareholder voting results for director elections and ratification of PwC as auditor for 2026.

Expected impact

Likely limited near-term impact; any reaction would be sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing only confirms outcomes of the June 9, 2026 annual meeting proposals (board nominees and auditor ratification) with no additional business developments.

Market effects

Sector

Minimal; governance/auditor ratification does not change biotech sector fundamentals.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even routine votes can matter if investors were uncertain about governance/auditor continuity, but this filing provides no such disruption signal.

Key entities

  • issuer
    Upstream Bio, Inc.

    Nasdaq-listed company filing the 8-K with final shareholder vote results.

  • director_nominee
    H. Edward Fleming, Jr., M.D.

    Elected as Class II director (Proposal 1).

  • director_nominee
    Liam Ratcliffe, M.B.Ch.B., Ph.D., M.B.A.

    Elected as Class II director (Proposal 1).

  • auditor
    PricewaterhouseCoopers LLP (PwC)

    Ratified as independent registered public accounting firm for 2026 (Proposal 2).

Read at source← All news

Related articles

AUG 9
$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

yahoo.com6 min
AUG 9
$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

rttnews.com2 min
AUG 9
$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

rte.ie6 min
AUG 9
$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

yahoo.com6 min
AUG 8
$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.

simplywall.st6 min